Physician Assistant in Jackson, TN Accepting Medicare

42 Physician Assistant nurses found. Showing 41 - 42

Mr. Dale R Lindsey, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 569 Skyline Dr, Suite 100, Jackson, TN 38301 Phone: 731-427-7888    Fax: 731-265-4159

Jessica A Herron, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2863 Highway 45 Byp, Jackson, TN 38305 Phone: 731-664-1375    Fax: 731-660-8368

News Archive

New project could help healthcare providers plan for coronavirus consequences

Could COVID-19 harm patients after the infection has gone? Members of the EUROMENE COST Action are adapting their work on chronic fatigue syndrome to coronavirus patients.

CMAJ study summarizes risk factors for severe outcome among patients admitted to hospital with H1N1

A new study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.091823 of all patients in Canada admitted to hospital for H1N1 in the first five months of the outbreak summarizes the risk factors for a severe outcome (www.cmaj.ca). The H1N1 pandemic presents important learnings for clinicians and researchers and data on severe outcomes can help inform future treatment and prevention guidelines.

Patients' own stem cells offer a step toward improving motor, sensory function after spinal cord injury

Stem cells derived from a patient's own fat offer a step toward improving -; not just stabilizing - motor and sensory function of people with spinal cord injuries, according to early research from Mayo Clinic.

DaVita to locate new headquarters building in a lot adjacent to Millennium Bridge

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, announced today it will locate its new headquarters building in a lot adjacent to the Millennium Bridge, at the west end of the 16th Street Mall, across from the new Union Station development. Construction will begin in early 2011 and DaVita expects to begin occupying the building in the second half of 2012.

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.

Read more Medical News

› Verified 8 days ago

• 1
• 2
• 3(current)